Suchergebnisse - NeurOscience GmbH

Brain Fingerprint Technology Market Projected to Reach USD 6,177.77 Million by 2032: The global Brain Fingerprint Technology market size is projected to be worth around USD 6,177.77 Million by 2032 and growing at a CAGR of 6.3% between 2024 and 2032 Report published by IMIR Market Research Pvt. Ltd. Report featuring the companies Brainwave Science, Brain Fingerprinting Laboratories, Brainwave Science, LABORATORIES, BRAINCO, NEUROLOGIC RESEARCH, STOTT INTERNATIONAL, BRAINWAVES, COGNISURE, NEUFLEX NEUROTECHNOLOGY, AXILUM INC, BRAIN DYNAMICS, NEUROTECHNOLOGY SOLUTIONS, BRAINLOCK, C

Volltext

Biogen Idec International Neuroscience GmbH and University of Zurich File Patent Application for Anti-alpha Synuclein Binding Molecules

“… The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "Provided is anti-human a synuclein specific binding …”
Volltext

Biogen Idec International Neuroscience GmbH and University of Zurich File Patent Application for Human Anti Tau Antibodies

“… The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "Provided are human tau specific antibodies as well as …”
Volltext

Biogen International Neuroscience GmbH Files Patent Application for a Method of Reducing Brain Amyloid Plaques using Anti a Antibodies

“… The abstract of the patent published by the Controller General of Patents, Designs & Trade Marks states: "This disclosure relates to the use of anti-Ab …”
Volltext

State Intellectual Property Office of China Publishes Biogen Idec International Neuroscience GmbH and Bussiere Thierry's Patent Application for a Method of Reducing Brain Amyloid Plaques Using Anti-A Antibodies

Volltext

Biogen Idec International Neuroscience GmbH and University of Zurich Seek Patent for Anti-Alpha Synuclein Binding Molecules

Volltext

State Intellectual Property Office of China Releases Biogen Idec International Neuroscience GmbH and University of Zurich's Patent Application for Anti-Alpha Synuclein Binding Molecules

Volltext

Biogen Idec International Neuroscience GmbH Files Patent Application for Use of an Anti a Synuclein Antibody to Diagnose an Elevated Level of a Synuclein in the Brain

“… According to the Controller General of Patents, Designs & Trade Marks, "This disclosure relates to the use of anti-a-synuclein antibody to diagnose an elevated …”
Volltext

Univ Zuerich and Biogen Idec Internat Neuroscience GmbH Files Australian Patent Application for TDP-43 Specific Binding Molecules

Volltext

Univ Zuerich and Biogen Idec Internat Neuroscience GmbH File Australian Patent Application for Anti-Alpha Synuclein Binding Molecules

Volltext

Biogen Idec Internat Neuroscience GmbH and Univ Zuerich File WIPO Patent Application for TDP-43 Specific Binding Molecules

Volltext

Biogen Idec Internat Neuroscience GmbH, Weihofen Andreas, Engber Thomas and Grimm Jan File WIPO Patent Application for Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the Brain

Volltext

Estee Lauder Companies GmbH: La Mer Neuroscientist to Reveal New Insights Into Skin-Sensory Neuron Inflammation at Neuroscience 2024

Volltext

Axon Neuroscience Forschungs-Und Entwicklungs GmbH Files Patent Application for Tau Proteins

“… According to the Controller General of Patents, Designs & Trade Marks, Invention relates to antibodies with a specificity to an abnormally truncated form of …”
Volltext

Axon Neuroscience Forschungs-Und Entwicklungs GmbH Receives Patent for Antibody with a Specificity for Truncated Forms of Human Tau Protein and a Kit Thereof

“… According to the Controller General of Patents, Designs & Trade Marks, "Antibody with a specificity for truncated forms of human tau protein, being truncated …”
Volltext

Axon Neuroscience Forschungs Und Entwickklungs GmbH Files Patent Application for Antibody with a Specificity for Truncated Forms of Human Tau and a Kit Thereof

“… According to the Controller General of Patents, Designs & Trade Marks, "Invention relates to antibodies with a specificity to an abnormally truncated form of …”
Volltext

BioCrea GmbH: BioCrea's Anti Depression Program Voted Top Neuroscience Project to Watch

“… BioCrea uses this expertise in an innovative multi-parameter optimization approach to generate and deliver CNS drug candidates that offer significant potential …”
Volltext

BioCrea GmbH: BioCreas Anti-Depressiva-Programm zum 'Top Neuroscience Project to Watch' gewählt

Volltext

Evotec Neurosciences GmbH and Evotec AG Get Patent for Azetidines as Histamine H3 Receptor Antagonists

Volltext

Evotec Neurosciences GmbH and Evotec AG Get Patent for Azetidines and Cyclobutanes as Histamine H3 Receptor Antagonists

Volltext